396 related articles for article (PubMed ID: 25500839)
1. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
[TBL] [Abstract][Full Text] [Related]
2. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.
van Heeckeren AM; Schluchter MD; Drumm ML; Davis PB
Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L944-52. PubMed ID: 15246977
[TBL] [Abstract][Full Text] [Related]
3. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
[TBL] [Abstract][Full Text] [Related]
4. Blocking TNF-α enhances Pseudomonas aeruginosa-induced mortality in burn mice through induction of IL-1β.
Tsay TB; Yang MC; Chen PH; Lai KH; Huang HT; Hsu CM; Chen LW
Cytokine; 2013 Jul; 63(1):58-66. PubMed ID: 23623770
[TBL] [Abstract][Full Text] [Related]
5. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice.
O'Sullivan R; Carrigan SO; Marshall JS; Lin TJ
Immunobiology; 2008; 213(6):469-79. PubMed ID: 18514749
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
[TBL] [Abstract][Full Text] [Related]
8. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
9. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
10. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
14.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC.
Taylor PR; Bonfield TL; Chmiel JF; Pearlman E
Clin Immunol; 2016 Sep; 170():53-60. PubMed ID: 27155366
[TBL] [Abstract][Full Text] [Related]
16. Chronic
Mackowiak C; Marchiol T; Paljetak HC; Fauconnier L; Palomo J; Secher T; Panek C; Sedda D; Savigny F; Erard F; Bragonzi A; Huaux F; Stoeger T; Schiller HB; Sirard JC; Le Bert M; Couillin I; Quesniaux VFJ; Togbe D; Ryffel B
Immunohorizons; 2021 May; 5(5):273-283. PubMed ID: 33958388
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary immune cells and inflammatory cytokine dysregulation are associated with mortality of IL-1R1
Guo L; Wang YC; Mei JJ; Ning RT; Wang JJ; Li JQ; Wang X; Zheng HW; Fan HT; Liu LD
Zool Res; 2017 May; 38(3):146-154. PubMed ID: 28585438
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa colonization enhances ventilator-associated pneumonia-induced lung injury.
Tsay TB; Jiang YZ; Hsu CM; Chen LW
Respir Res; 2016 Aug; 17(1):101. PubMed ID: 27506464
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
